Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis

American Journal of Gastroenterology

Volumn 96, Issue 4, 2001, Pages 1210-1216

  Lee, Wui Chiang ^b   Lin, Han Chieh ^a   Yang, Ying Ying ^b   Hou, Ming Chih ^b   Lee, Fa Yauh ^b   Chang, Full Young ^b   Lee, Shou Dong ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZOSIN; TERLIPRESSIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; LIVER CLEARANCE; MALE; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; VIRUS HEPATITIS;

ANTIHYPERTENSIVE AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LYSINE VASOPRESSIN; MALE; MIDDLE AGED; PRAZOSIN;

EID: 0035046241     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02268-7     Document Type: Article

References (48)

1. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis
2. Portal pressure, presence of gastroesophageal varices and variceal bleeding
3. Pharmacological treatment of portal hypertension: Hemodynamic effects and prevention of bleeding
4. The treatment of portal hypertension: A meta-analytic review
5. Medical treatment of portal hypertension
6. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension
7. Systemic and portal hemodynamic changes following triglycyllysine vasopressin plus nitroglycerin administration in patients with hepatitis B-related cirrhosis
8. Hemodynamic effects of a combination of vasopressin and ketanserin in patients with hepatitis B-related cirrhosis
9. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis
10. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mono-nitrate in the treatment of portal hypertension
11. Haemodynamic effects of a combination of propranolol and clonidine in patients with post-hepatitic cirrhosis
12. Conversion of triglycylvasopressin to lysine-vasopressin in man
13. Terlipressin in bleeding esophageal varices: A placebo-controlled, double-blind study
14. Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding
15. Terlipressin controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial
16. Double-blind randomized controlled trial comparing terlipressin, and somatostatin for acute variceal hemorrhage
17. Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis
18. Comparison of vasopressin and triglycyl-lysine vasopressin on splanchnic and systemic hemodynamics in dogs
19. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol
20. The effect of vasopressin and triglycyl lysine vasopressin (glypressin) on the splanchnic circulation in cirrhotic patients with portal hypertension
21. Hemodynamic changes of systemic, hepatic, and splenic circulation following triglycyl-lysin-vasopressin administration in alcoholic cirrhosis
22. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients
23. Comparisons of the hemodynamic responses to ketanserin and prazosin in portal hypertensive rats
24. Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension
25. Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension
26. Continuous prazosin administration in cirrhotic patients: Effects on portal hemodynamics and on liver and renal function
27. Influence of pharmacological agents on portal hemodynamics: Basis for its use in the treatment of portal hypertension
28. Transection of oesophagus for bleeding oesophageal varices
29. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis
30. Comparison between portal vein pressure and wedged hepatic vein pressure in hepatitis B-related cirrhosis
31. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis
32. Thermodilution cardiac output determination with a single flow-directed catheter
33. Pharmacokinetics of prazosin in man
34. Time profile of the hemodynamic effects of terlipressin in portal hypertension
35. The physiological basis for clearance measurements in hepatology
36. Effect of triglycyllysin-vasopressin on quantitative liver function tests in patients with cirrhosis
37. Differential response of normal and cirrhotic liver to vasoactive agents. A study in the isolated perfused rat liver
38. Effects of hepatic nerves, norepinephrine, angiotensin, elevated central venous pressure on postsinusoidal resistance sites and intrahepatic pressure
39. Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat
40. Hemodynamic events in a prospective randomized clinical trial of propranolol versus placebo in the prevention of a first variceal hemorrhage
41. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal hemorrhage in patients with cirrhosis
42. Total and renal sympathetic nervous system activity in alcoholic cirrhosis
43. Mechanism of a clonidine-induced decrease in portal pressure in normal and cirrhotic conscious rats
44. Increased sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis
45. Hemodynamic effects of a combination of clonidine and propranolol in conscious cirrhotic rats
46. Haemodynamic effects of a combination of propranolol and clonidine in patients with post-hepatitic cirrhosis
47. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mono-nitrate in the treatment of portal hypertension